Mehmet H. Kural
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mehmet H. Kural has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- Laura E. Niklason
Anesthesiology, Yale University, New Haven, CT, United States
4 shared publications Jiesi Luo
Yale Cardiovascular Research Center, Department of Internal Medicine, School of Medicine, Yale University, New Haven, CT06519, USA
3 shared publicationsJuan Wang
Humacyte, Inc, Durham, NC (K.M.N., M.H.K., Y.L., J.W., E.A.H., L.E.N.).
3 shared publicationsJinkyu Park
Yale Cardiovascular Research Center, Department of Internal Medicine, School of Medicine, Yale University, New Haven, USA
2 shared publications- Yibing Qyang
Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
2 shared publications - Allison Marie Greaney
Yale University
1 shared publication
Latest Publications
- Open Access
- 22 June 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (6) , 1-11
Mechano-inhibition of endocytosis sensitizes cancer cells to Fas-induced Apoptosis
The transmembrane death receptor Fas transduces apoptotic signals upon binding its ligand, FasL. Although Fas is highly expressed in cancer cells, insufficient cell surface Fas expression desensitizes cancer cells to Fas-induced apoptosis. Here, we show that the increase in Fas microaggregate formation on the plasma membrane in response to the inhibition of endocytosis sensitizes cancer cells to Fas-induced apoptosis. We used a clinically accessible Rho-kinase inhibitor, fasudil, that reduces endocytosis dynamics by increasing plasma membrane tension. In combination with exogenous soluble FasL (sFasL), fasudil promoted cancer cell apoptosis, but this collaborative effect was substantially weaker in nonmalignant cells. The combination of sFasL and fasudil prevented glioblastoma cell growth in embryonic stem cell-derived brain organoids and induced tumor regression in a xenograft mouse model. Our results demonstrate that sFasL has strong potential for apoptosis-directed cancer therapy when Fas microaggregate formation is augmented by mechano-inhibition of endocytosis.
- 22 June 2024
- Published by Springer Nature in Cell Death & Disease
- Vol. 15 (6) , 1-11
Open AccessMechano-inhibition of endocytosis sensitizes cancer cells to Fas-induced Apoptosis
The transmembrane death receptor Fas transduces apoptotic signals upon binding its ligand, FasL. Although Fas is highly expressed in cancer cells, insufficient cell surface Fas expression desensitizes cancer cells to Fas-induced apoptosis. Here, we show that the increase in Fas microaggregate formation on the plasma membrane in response to the inhibition of endocytosis sensitizes cancer cells to Fas-induced apoptosis. We used a clinically accessible Rho-kinase inhibitor, fasudil, that reduces endocytosis dynamics by increasing plasma membrane tension. In combination with exogenous soluble FasL (sFasL), fasudil promoted cancer cell apoptosis, but this collaborative effect was substantially weaker in nonmalignant cells. The combination of sFasL and fasudil prevented glioblastoma cell growth in embryonic stem cell-derived brain organoids and induced tumor regression in a xenograft mouse model. Our results demonstrate that sFasL has strong potential for apoptosis-directed cancer therapy when Fas microaggregate formation is augmented by mechano-inhibition of endocytosis.
- Open Access
- 24 June 2022
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 131 (1) , 109-126
Bioengineering Human Tissues and the Future of Vascular Replacement
Cardiovascular defects, injuries, and degenerative diseases often require surgical intervention and the use of implantable replacement material and conduits. Traditional vascular grafts made of synthetic polymers, animal and cadaveric tissues, or autologous vasculature have been utilized for almost a century with well-characterized outcomes, leaving areas of unmet need for the patients in terms of durability and long-term patency, susceptibility to infection, immunogenicity associated with the risk of rejection, and inflammation and mechanical failure. Research to address these limitations is exploring avenues as diverse as gene therapy, cell therapy, cell reprogramming, and bioengineering of human tissue and replacement organs. Tissue-engineered vascular conduits, either with viable autologous cells or decellularized, are the forefront of technology in cardiovascular reconstruction and offer many benefits over traditional graft materials, particularly in the potential for the implanted material to be adopted and remodeled into host tissue and thus offer safer, more durable performance. This review discusses the key advances and future directions in the field of surgical vascular repair, replacement, and reconstruction, with a focus on the challenges and expected benefits of bioengineering human tissues and blood vessels.
- 24 June 2022
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 131 (1) , 109-126
Open AccessBioengineering Human Tissues and the Future of Vascular Replacement
Cardiovascular defects, injuries, and degenerative diseases often require surgical intervention and the use of implantable replacement material and conduits. Traditional vascular grafts made of synthetic polymers, animal and cadaveric tissues, or autologous vasculature have been utilized for almost a century with well-characterized outcomes, leaving areas of unmet need for the patients in terms of durability and long-term patency, susceptibility to infection, immunogenicity associated with the risk of rejection, and inflammation and mechanical failure. Research to address these limitations is exploring avenues as diverse as gene therapy, cell therapy, cell reprogramming, and bioengineering of human tissue and replacement organs. Tissue-engineered vascular conduits, either with viable autologous cells or decellularized, are the forefront of technology in cardiovascular reconstruction and offer many benefits over traditional graft materials, particularly in the potential for the implanted material to be adopted and remodeled into host tissue and thus offer safer, more durable performance. This review discusses the key advances and future directions in the field of surgical vascular repair, replacement, and reconstruction, with a focus on the challenges and expected benefits of bioengineering human tissues and blood vessels.
- 29 May 2021
- Published by Elsevier in Biomaterials
- Vol. 275, 120911
An ex vivo physiologic and hyperplastic vessel culture model to study intra-arterial stent therapies
- 29 May 2021
- Published by Elsevier in Biomaterials
- Vol. 275, 120911
An ex vivo physiologic and hyperplastic vessel culture model to study intra-arterial stent therapies
- 1 January 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 119, 155-168
Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering
- 1 January 2021
- Published by Elsevier in Acta Biomaterialia
- Vol. 119, 155-168
Xenogeneic-free generation of vascular smooth muscle cells from human induced pluripotent stem cells for vascular tissue engineering
- 1 January 2020
- Published by Elsevier in Acta Biomaterialia
- Vol. 102, 220-230
Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes
- 1 January 2020
- Published by Elsevier in Acta Biomaterialia
- Vol. 102, 220-230
Modular design of a tissue engineered pulsatile conduit using human induced pluripotent stem cell-derived cardiomyocytes
- 1 March 2016
- Published by Elsevier in Acta Biomaterialia
- Vol. 32, 223-230
Myofibroblast persistence with real-time changes in boundary stiffness
- 1 March 2016
- Published by Elsevier in Acta Biomaterialia
- Vol. 32, 223-230
Myofibroblast persistence with real-time changes in boundary stiffness
- 22 June 2011
- Published by ASME International
- p. 763-764
Planar Biaxial Characterization of Human Coronary and Carotid Arteries for Computational Modeling
Finite element analyses (FEA) provide contributions to clinical cardiovascular applications such as assessment of plaque vulnerability, the mechanical optimization of balloon angioplasty and stent deployment. However, FEA-predicted stresses for physiological and pathological states are dependent heavily on the accuracy of material models utilized. Thus, developing accurate quantitative descriptions for the multiaxial mechanical behavior of blood vessels is essential for developing accurate computational models for arterial stiffness.
- 22 June 2011
- Published by ASME International
- p. 763-764
Planar Biaxial Characterization of Human Coronary and Carotid Arteries for Computational Modeling
Finite element analyses (FEA) provide contributions to clinical cardiovascular applications such as assessment of plaque vulnerability, the mechanical optimization of balloon angioplasty and stent deployment. However, FEA-predicted stresses for physiological and pathological states are dependent heavily on the accuracy of material models utilized. Thus, developing accurate quantitative descriptions for the multiaxial mechanical behavior of blood vessels is essential for developing accurate computational models for arterial stiffness.
- 25 June 2008
- Published by ASME International
- p. 307
Boundary Stiffness Regulates Fibroblast Behavior in Collagen Gels
Recent studies utilizing compliant culture substrates clearly demonstrate that many cell behaviors such as migration and contraction are strongly influenced by the stiffness of the local environment. The goal of this work was to develop a method for studying stiffness-dependent biology within 3D cell-populated gels without altering the biochemical environment of the gel. A device was developed utilizing compliant anchors to tune the boundary stiffness of suspended collagen gels. Human fibroblasts compacted the gels to a greater extent as the stiffness of the anchors was decreased. Further, the force generated by the cells increased with increased boundary stiffness, and the response of the cells to TGF-β1 was accentuated as the stiffness increased. This new method represents a promising tool for the controlled study of stiffness-dependent biology within tissuelike 3D environments.
- 25 June 2008
- Published by ASME International
- p. 307
Boundary Stiffness Regulates Fibroblast Behavior in Collagen Gels
Recent studies utilizing compliant culture substrates clearly demonstrate that many cell behaviors such as migration and contraction are strongly influenced by the stiffness of the local environment. The goal of this work was to develop a method for studying stiffness-dependent biology within 3D cell-populated gels without altering the biochemical environment of the gel. A device was developed utilizing compliant anchors to tune the boundary stiffness of suspended collagen gels. Human fibroblasts compacted the gels to a greater extent as the stiffness of the anchors was decreased. Further, the force generated by the cells increased with increased boundary stiffness, and the response of the cells to TGF-β1 was accentuated as the stiffness increased. This new method represents a promising tool for the controlled study of stiffness-dependent biology within tissuelike 3D environments.
- 20 June 2007
- Published by ASME International
- p. 979
Mechanical and Biochemical Comparison of Cell-Derived Matrix, Collagen Gels, and Fibrin Gels for Tissue Engineering Applications
Cell-seeded collagen and fibrin gels have been used extensively as in vitro wound healing models and for studying tissue remodeling. The have also been utilized as replacements for lost or damaged connective tissue [1]. The major drawback of these gel-based living tissue equivalents (LTEs) for tissue engineering applications is that they are not completely synthesized and arranged by the cells themselves, thus they are weak relative to native connective tissue.
- 20 June 2007
- Published by ASME International
- p. 979
Mechanical and Biochemical Comparison of Cell-Derived Matrix, Collagen Gels, and Fibrin Gels for Tissue Engineering Applications
Cell-seeded collagen and fibrin gels have been used extensively as in vitro wound healing models and for studying tissue remodeling. The have also been utilized as replacements for lost or damaged connective tissue [1]. The major drawback of these gel-based living tissue equivalents (LTEs) for tissue engineering applications is that they are not completely synthesized and arranged by the cells themselves, thus they are weak relative to native connective tissue.